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Introduction: This study investigated racial disparities in postsurgi-
cal health-related quality of life (HRQOL) among patients with non–
small-cell lung cancer (NSCLC).
Methods: Data were collected by the Cancer Care Outcomes 
Research and Surveillance Consortium. Inclusion criteria were 
greater than or equal to 21 years of age, NSCLC, and receipt of sur-
gery. HRQOL data were available from patients' surveys, and com-
plete medical record abstraction was performed to obtain clinical 
data. HRQOL was assessed by the physical/mental component sum-
mary scores (PCS/MCS) of the 12-item Short-Form Health Survey 
at two time points. Mean time between surgery and the initial assess-
ment (time 1) after surgery was 4.1 (SD 2.2) months and between 
surgery and second assessment (time 2) was 12.7 (SD 3.8) months. 
Multivariable linear regression models were used to examine asso-
ciations between race and HRQOL.
Results: Of 650 patients, 80.5% were White, 8.8% Black, and 
10.7% other races. At second assessment, Blacks reported lower 
MCS than Whites (47.4 versus 52.6, p = 0.002). In multivariable 
analysis, Blacks had lower MCS compared with Whites. No dif-
ference was found between Whites and Blacks on PCS. Those with 
less than high school education reported lower MCSs. Older age 
and receipt of adjuvant chemotherapy after surgery were associated 
with gain in MCS. Male, less than college education, and comor-
bidities were associated with impaired PCS. Older age was associ-
ated with improved PCS.
Conclusion: Racial disparities exist in postoperative mental HRQOL. 
Results highlight the need for interventions after lung cancer surgery 
to improve mental health in Black and younger patients.
Key Words: Non–small-cell lung cancer, Surgery, Racial disparities, 
Health-related quality of life.
(J Thorac Oncol. 2015;10: 1404–1412)
Lung cancer is the leading cause of cancer-related death in the United States. It is estimated that there will be 224,210 
new lung cancer cases and 159,260 deaths from lung cancer 
in 2014.1 Blacks suffer a greater burden of disease from lung 
cancer compared with other racial/ethnic groups and tend 
to have higher prevalence and mortality from lung cancer.2,3 
Despite advances in treatment, compared with Whites, Blacks 
with lung cancer have lower 5-year survival rates (16% versus 
13%),4 are less likely to undergo invasive staging,5 and receive 
surgical resection less frequently (63.4% versus 44.7%).6
Surgical resection remains the best available treatment 
to enhance long-term survival for patients with early-stage 
(stages I and II) non–small-cell lung cancer (NSCLC). The 
5-year postoperative survival rate for patients with stage I 
NSCLC ranges from 55% to 72%. If not treated surgically, the 
5-year survival rate ranges from 4% to 14%.7 However, lung 
cancer surgery has the potential to negatively affect health-
related quality of life (HRQOL).8–10 Studies have reported that 
HRQOL was lower during the first 3 to 6 months after surgery 
and then improved over time.9,11,12 A recent study found that at 
6 months after lung cancer surgery 59% of patients reported 
lower physical HRQOL and 33% reported lower mental 
HRQOL compared with preoperative HRQOL.8
HRQOL in patients with lung cancer from different 
racial groups is of particular interest because when com-
pared with their White counterparts, Black patients have 
poorer HRQOL,13 and it has been found that poor HRQOL is 
strongly associated with increased risk of death among lung 
cancer patients.14 In fact, 10% decrease in physical and mental 
HRQOL during the first 6 months after lung cancer surgery 
was associated with 18% and 13% increased risk of death, 
respectively.14 The relationship between an individual’s racial 
background and postoperative HRQOL is complex and may 
be mediated by patients’ demographic, socioeconomic (e.g., 
income, education), and clinical (e.g., disease stage, comor-
bidities) characteristics. Previous studies demonstrated that 
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Blacks are more likely than Whites to report lower household 
income,6,15 education attainment,6,16 being uninsured or cov-
ered by Medicaid,6,17,18 being unmarried,6,19 being diagnosed at 
advanced-stage lung cancer (stage III or IV),18,20 at a younger 
age,20 have greater prevalence of comorbidities,21,22 and less 
likely to successfully quit smoking,23 and all these factors 
are associated with HRQOL of lung cancer patients.10,24–27 
Although several studies examining HRQOL after lung resec-
tion have been conducted over the past decade,10 the relation-
ship between race and HRQOL is poorly understood. Literature 
suggests that several factors (e.g., higher rates of poverty, lack 
of health insurance, more advanced stage at diagnosis) may 
account for a substantial part of the observed racial/ethnic 
differences in lung cancer outcomes.28,29 To our knowledge, 
no studies have analyzed the effect of race on HRQOL while 
controlling for these important factors. Thus, we performed a 
prospective population-based study to investigate racial dis-
parities in postsurgical HRQOL among a cohort of patients 
with newly diagnosed NSCLC and identified characteristics 
associated with HRQOL after lung cancer surgery. Because 
prior research indicates substantial racial/ethnic differences 
in lung cancer outcomes,2,28,30,31 it is possible that differences 
regarding HRQOL after surgical procedure may also exist. We 
hypothesized that Blacks would report less improvement in 
physical and mental HRQOL than Whites after controlling for 
demographic, socioeconomic, and clinical factors. To enhance 
HRQOL after lung cancer surgery, it is important to identify 
subgroups of lung cancer patients with an increased risk of 
poor HRQOL, then to develop appropriate interventions that 
can be delivered after lung cancer surgery. Enhancing HRQOL 
after lung cancer surgery might ultimately improve survival.
MATERIALS AND METHODS
Data Source
Data for this study were collected by the Cancer 
Care Outcomes Research and Surveillance (CanCORS) 
Consortium. The consortium examined variations in care 
and outcomes of care for patients with newly diagnosed lung 
and colorectal cancers between 2003 and 2005 with follow-
up data for as long as 15 months after diagnosis.32 Data were 
collected from patient surveys, medical records abstraction, 
physician surveys, and surveys of informal caregivers using 
computer-assisted telephone interviews in English, Spanish, 
and Mandarin and Cantonese Chinese.33 Details on study 
design and procedures have been previously published.32,34 
Patients were living in Northern California, Los Angeles 
County, North Carolina, Alabama, Iowa, or received care in 
one of the five large integrated health care systems or in one 
of the 15 Veterans Health Administration hospitals. In 2004, 
the study catchment areas included nearly 30 million people, 
representing 10% of the United States population.32,33 Human 
subjects committees at all participating institutions approved 
the study. In this analysis, we used data from two different 
sources: (1) patient surveys obtained approximately 4 months 
after diagnosis (time 1) and again approximately 11 to 13 
months after diagnosis (time 2) and (2) medical records from 
physicians involved in the patients’ cancer care from 3 months 
before to 15 months after diagnosis.32 The majority of newly 
diagnosed lung cancer patients had surgery before the first 
patient survey (time 1).
Study Population
Forty-nine percent of eligible patients with lung cancer 
participated in the CanCORS study.34 Comparisons of respond-
ers and nonresponders have been described previously.35 In the 
CanCORS sites affiliated with Surveillance, Epidemiology, 
and End Results registries, the CanCORS cohort was similar 
to Surveillance, Epidemiology, and End Results in ethnic dis-
tribution (Black, 11.8% versus 9.8%; Hispanic, 4.8% versus 
5.3%; Asian, 3.6% versus 4.7%).34
In the CanCORS cohort, there were a total of 1228 
patients aged greater than or equal to 21 years with diagno-
ses of NSCLC who received primary surgery and had accom-
panying medical records data available (Fig. 1). Then, 109 
patients were dropped because they lacked at least 3 months 
between the baseline and follow-up surveys. The HRQOL 
data were available from baseline and follow-up surveys from 
844 patients. Another 194 observations were dropped because 
of lost from nonimputed items in the 844 patients with at 
least some data from both the baseline and follow-up survey. 
The CanCORS team applied sequential iterative imputation 
algorithms to fill in many missing items but excluding cer-
tain patient attributes that could not be accurately imputed, 
e.g., race. Multiple imputed models were only constructed for 
Eligible lung cancer patients with
MD consent, MR consent, and
baseline and follow-up survey data
(n=3,893)
NSCLC diagnosis with primary
surgery information available in
MRA
(n=1,228)
Had at least 3 months between
surgery and follow-up survey, stages
I, II or IIIA at diagnosis
(n=1,119)
HRQOL data available from baseline
and follow-up surveys
(n=844)
Complete data on all study variables
(n=650)
Whites
(n=523)
Blacks
(n=57)
Other
(n=70)
FIGURE 1.  Study cohort, cancer care outcomes research and 
surveillance cohort selection. HRQOL, health-related quality of 
life; MD, medical doctor; MR, medical record; MRA, medical 
record abstraction; NSCLC, Non–small-cell lung cancer.
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CanCORS patient surveys. There were multiple versions of 
each patient survey (e.g., a “brief ” version for patients too 
sick to complete an entire survey), and data missing because 
of survey type were not imputed. For example, patients who 
completed the brief survey were not asked about their smok-
ing status or insurance information, so we did not imputed 
values for those patients.36,37 This resulted in 650 patients with 
complete data on all covariates.
A nonresponse analysis (available on request) of the 194 
patients with incomplete data indicated that they were more 
likely to be younger, black, married or living with a partner, 
and more educated with higher incomes. Over 50% of sub-
jects with incomplete, nonimputable data reportedly had stage 
IIIB/IV cancer, which resulted in no patients in these stages 
in the final analytic sample. Multivariate regression is used to 
control for any systematic effects that sample deletions may 
have had on HRQOL.
HRQOL Assessment
The Medical Outcomes Study 12-item Short-Form 
Health Survey (SF-12) was used to measure HRQOL.38 This 
measure has two subscales: physical component summary 
(PCS; six items) and mental component summary (MCS; six 
items). The PCS is based on physical functioning, role limi-
tations as a result of physical health problems, bodily pain, 
and general health perception domains. The MCS is based on 
general mental health, role limitations as a result of emotional 
problems, social functioning, and vitality domains. The two 
summary measures use norm-based scoring algorithms that 
are standardized by the sample mean (50) and standard devia-
tion (10) of the general population. Higher scores on SF-12 
indicate better quality of life, and higher summary scores 
reflected better mental and physical health.38 HRQOL was 
assessed at two time points after lung cancer surgery. Mean 
time between surgery and time 1 assessment after surgery was 
4.1 (SD 2.2) months, and between surgery and time 2 assess-
ment was 12.7 (SD 3.8) months.
Covariates
Race, age, sex, and marital status were obtained from 
the time 1 patient survey. For patients with no response to 
the interview item, data were obtained from medical record 
abstraction or if both data sources were missing, from track-
ing records. Annual household income, education, insurance, 
smoking status, and social support also came from the time 
1 assessment. Emotional/informational and tangible support 
was measured using the Medical Outcomes Study Social 
Support Survey, administered during the time 1 survey.39
Clinical characteristics, including disease stage at the 
time of diagnosis, receipt of adjuvant chemotherapy, comor-
bidity, and types of lung cancer surgery, were abstracted 
from medical records. Collaborative stage (American Joint 
Committee on Cancer)40 at the time of diagnosis was catego-
rized as stage I, stage II, or stage IIIA. Receipt of adjuvant 
chemotherapy was indicated within 6 months of lung cancer 
surgery. Comorbidity at the time of diagnosis was measured 
using the Adult Comorbidity Evaluation 27 instrument, a 
27-item index that was developed and validated for patients 
with cancer.41 Surgery type was categorized as limited resec-
tion, lobectomy/bilobectomy, or pneumonectomy. To control 
for varying recovery times between surgery and follow-up 
assessment, we created a time-since-surgery variable based 
on the difference between the time of surgery and the second 
assessment.
Statistical Analysis
Baseline characteristics between Blacks and Whites 
were compared using a χ2 test. Two-sample t tests were used 
to compare social support and HRQOL differences between 
Whites and Blacks. We used multivariable linear regressions 
to model the effect of race on PCS and MCS by sequentially 
controlling for patient sociodemographic and clinical factors. 
The dependent variables for the analysis, PCSs and MCSs, 
were based on the second assessment. Three separate linear 
regression models were estimated for PCS and MCS. The 
first model included patients’ HRQOL scores from time 1 
assessment, race, age, sex, and time since surgery. Including 
baseline HRQOL scores requires regression coefficients to 
be interpreted as the difference in follow-up HRQOL scores 
between baseline and follow-up within each reference group 
(e.g., white females). In the second model, we added mediating 
variables including marital status, income, education, smok-
ing status, and social support. These variables are thought to 
influence HRQOL and patients’ lung cancer condition and 
being influenced by the basic demographic characteristics. 
In the final model, we added insurance, comorbidity, disease 
stage, type of surgery, and adjuvant chemotherapy. Now, coef-
ficients in models 1 and 2 are interpreted after controlling 
for cancer condition such as comorbidities. We used patient 
survey V1.11, MRA V1.12, and core V1.14. A two-sided 
p value less than or equal to 0.05 was used to indicate statisti-
cal significance. Analyses were performed using SAS version 
9.2 (SAS Institute, Cary, NC).
RESULTS
Sample Characteristics
Of the 650 patients, 80.5% were White, 8.8% were 
Black, and 10.7% were of other race. Blacks, Whites, and 
other patients did not differ significantly in most demographic 
and clinical characteristics with the exception of education and 
income. Compared with Whites and others, Blacks were less 
educated (p = 0.03) and had lower income (p = 0.05). More 
Blacks (24.5%) had less than a high-school level education 
compared with Whites (15.5%) and others (18.6%). Overall 
19% of the respondents reported having a bachelor’s degree or 
higher, but this was most often the case for Whites (21.0%), 
followed by others (14.3%), then Blacks (7%). Similarly, a 
larger proportion of Blacks were in the lowest yearly house-
hold income bracket (less than $20,000; 38.6%) compared 
with Whites (24%) and others (20.0%; Table 1).
Black and White Difference in HRQOL
The PCSs and MCSs were comparable between Blacks 
and Whites at time 1 (Table 2), and no significant difference 
was found in PCSs between these two groups at time 2. The 
Copyright © 2015 by the International Association for the Study of Lung Cancer
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TABLE 1.  Patient Characteristics by Race (n = 650)
Characteristics
All Participants 
Frequencies (%)
White (n = 523) 
Frequencies (%)
Black (n = 57) 
Frequencies (%)
Other (n = 70) 
Frequencies (%) χ2 ρ
Age at diagnosis 10.2 0.11
  21–52 48 (7.4) 34 (6.5) 7 (12.3) 7 (10.0)
  53–64 199 (30.6) 151 (28.9) 22 (38.6) 26 (37.2)
  65–79 338 (52.0) 287 (54.9) 22 (38.6) 29 (41.4)
  ≥80 65 (10.0) 51 (9.7) 6 (10.5) 8 (11.4)
gender 1.9 0.37
  Male 358 (55.0) 284 (54.3) 30 (52.6) 44 (62.9)
  Female 292 (45.0) 239 (45.7) 27 (47.4) 26 (37.1)
Marital status 4.1 0.12
  Married/living with partner 396 (61.0) 322 (61.6) 28 (49.1) 46 (65.7)
  Not married 254 (39.0) 201 (38.4) 29 (50.9) 24 (34.3)
Education 2.56 0.03
  Not HS graduate 108 (16.6) 81 (15.5) 14 (24.5) 13 (18.6)
  HS/less BS degree 409 (63.0) 328 (62.7) 37 (65.0) 44 (62.8)
  BS degree or higher 124 (19.0) 110 (21.0) 4 (7.0) 10 (14.3)
  Missing 9 (1.4) 4 (0.8) 2 (3.5) 3 (4.3)
Income ($) 2.16 0.05
<20,000 161 (24.8) 125 (24.0) 22 (38.6) 14 (20.0)
  20,000 to <40,000 151 (23.2) 133 (25.4) 6 (10.5) 12 (17.1)
  40,000 to <60,000 107 (16.5) 90 (17.2) 6 (10.5) 11 (15.7)
  ≥60,000 103 (15.8) 88 (16.8) 6 (10.5) 9 (12.9)
  Missing 128 (19.7) 87 (16.6) 17 (29.8) 24 (34.3)
Insurance 0.83 0.50
  Private/VA/military 211 (32.5) 167 (31.9) 21 (36.8) 23 (32.8)
  Medicare 402 (61.8) 332 (63.5) 29 (50.9) 41 (58.6)
  Low income/other 13 (2.0) 8 (1.5) 2 (3.5) 3 (4.3)
  Missing 24 (3.7) 16 (3.1) 5 (8.8) 3 (4.3)
Smoking status 0.83 0.43
  Current smokers 63 (9.7) 50 (9.6) 5 (8.8) 8 (11.4)
  Nonsmokers 499 (76.8) 415 (79.3) 38 (66.7) 46 (65.7)
  Missing 88 (13.5) 58 (11.1) 14 (24.5) 16 (22.9)
Stage 8.0 0.08
  I 467 (71.8) 381 (72.8) 35 (61.4) 51 (72.9)
  II 120 (18.4) 94 (18.0) 11 (19.3) 15 (21.4)
  IIIA 63 (9.7) 48 (9.2) 11 (19.3) 4 (5.7)
Type of surgery 4.1 0.39
  Limited resection 143 (22.0) 113 (21.6) 13 (22.8) 17 (24.3)
   Lobectomy/Bilobectomy 410 (63.0) 338 (64.6) 34 (59.7) 38 (54.3)
   Pneumonectomy 97 (15.0) 72 (13.8) 10 (17.5) 15 (21.4)
  Adjuvant chemotherapy 2.3 0.31
  Yes 182 (28.0) 148 (28.3) 19 (33.3) 15 (21.4)
  No 468 (72.0) 375 (71.7) 38 (66.7) 55 (78.6)
Comorbidity 5.4 0.48
  None 89 (13.7) 75 (14.3) 5 (8.8) 9 (12.9)
  Mild 262 (40.3) 206 (39.4) 28 (49.1) 28 (40.0)
  Moderate 174 (26.8) 137 (26.2) 18 (31.6) 19 (27.1)
  Severe 125 (19.2) 105 (20.1) 6 (10.5) 14 (20.0)
Social support n = 468, Mean (SD) n = 44, Mean (SD) n = 54, Mean (SD)
  Emotional or informational 84.2 (21.8) 81.9 (21.8) 82.3 (23.2)
  Tangiblea 83.8 (24.1) 77.5 (25.6) 83.1 (25.7)
an = 465.
BS, Bachelor’s degree; HS, High School; SD, standard deviation; VA, Veteran’s administration.
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MCS, however, was significantly lower among Blacks than 
Whites (47.4 versus 52.6, p = 0.002) at time 2. No significant 
difference was found in PCSs between these two groups at 
time 2 (Table 2). The MCS, however, was a clinically signifi-
cant 11% lower among Blacks than Whites (47.4 versus 52.6, 
p = 0.002) at time 2.
Multivariable Analysis
The multiple linear regression results for PCSs and 
MCSs are presented in Tables 3 and 4, respectively. Covariates 
in the fully specified model (model 3) explained 42% of the 
variance in PCSs at time 2 (adjusted R2). There was no sig-
nificant association between PCSs at time 2 and race in all 
three models. In the full model (model 3), factors that were 
significantly associated with less gain in PCS included being 
male, lower education level, and comorbidities. Older patients 
showed substantial gains in PCSs after comorbidities were 
held constant in the model, implying that their compromised 
health status plays a major role in limiting their gains from 
surgery (as indicated by model 1). Marital status, income, 
insurance, social support, smoking status, and clinical char-
acteristics, including disease stage, type of surgery, time since 
surgery, and receipt of adjuvant chemotherapy, were not asso-
ciated with PCSs at time 2 (Table 3).
Covariates in the fully specified model accounted for 
39% of the variance in MCSs at time 2. Blacks had signifi-
cantly lower MCSs at time 2 than Whites in all three models. 
Older patients and those who received adjuvant chemother-
apy within 6 months of surgery exhibited significantly higher 
MCSs at time 2, whereas less educated patients reported lower 
MCS at time 2, holding all other factors constant. Male gen-
der was associated with higher MCSs at time 2 (Model 1), 
but, after controlling for all factors, there was no statistically 
significant difference based on gender. Marital status, income, 
insurance, social support, smoking status, and clinical char-
acteristics, such as disease stage, type of surgery, time since 
surgery, and comorbidity, were not associated with MCSs at 
time 2 (Table 4).
DISCUSSION
In this population-based prospective cohort study of 
patients who underwent surgery for lung cancer, we found 
that compared with Whites, Blacks had lower mental health 
scores at follow-up even after controlling for demographic 
and clinical factors. Thus, our study provided evidence sug-
gesting that there were racial disparities in the mental aspect 
of HRQOL after lung cancer surgery but not in the physical 
aspect of HRQOL. After lung cancer surgery, Black patients 
report lower self-reported mental health than Whites. One 
explanation may be that Blacks are more likely to have less 
access to psychosocial services than Whites,2 possibly because 
of lower incomes and educational attainment.42 Other factors 
may also impact mental health for blacks after surgery for 
NSCLC including cultural norms and stigma.43
To our knowledge, this is the first study that investi-
gated the effect of race on the postsurgical HRQOL among 
patients with NSCLC. No previous studies are available to 
compare the study findings with our study. However, a recent 
study, by Traeger et al.,31 investigated race by sex differences 
in depression symptoms among non-Hispanic Blacks and 
Whites with lung cancer using the Center for Epidemiologic 
Studies Depression Scale. Investigators reported that Black 
men (24.7%) had the highest prevalence of depression symp-
toms followed by White women (20.6%), Black women 
(15.8%), and White men (15.0%).31 Comparisons were not 
exact because Traeger et al.31 included all lung cancer patients 
regardless of treatment in their study sample, whereas, in our 
sample, we included only participants who had surgical treat-
ment for NSCLC. Taken together, findings of these studies 
provide evidence of significant differences in mental health 
between Whites and Blacks with lung cancer. The findings of 
this study highlight the need to assess psychosocial concerns 
before surgery and referral for psychosocial care as recom-
mended by the American College of Surgeon’s Commission 
on Cancer credentialing standards,44,45 to improve mental 
health after surgery for lung cancer. The beneficial effects of 
providing psychosocial care to cancer patients are well recog-
nized.46 This screening may identify patients who would ben-
efit from further assessment, psychosocial support programs, 
and treatment of significant mental health concerns. given 
the findings of this study, this may be especially important for 
Black patients receiving surgery for the treatment of NSCLC.
Additional findings in our study warrant special note. 
Our results are consistent with literature indicating that 
respondent education level, age, and gender are associated 
with HRQOL after lung cancer surgery.8,10,47 In this study, 
patients who did not graduate from high school had lower 
scores in physical and mental HRQOL than participants 
who had a bachelor’s degree or higher, confirming pre-
vious research that reported education as a risk factor for 
poor outcomes for lung cancer.48 Older age was associated 
with higher scores for both mental and physical health. One 
possible explanation is that older patients may process the 
experience of cancer and the benefits of surgery differently 
than younger patients. In addition, older patients may have 
well-developed life skills and more experience navigating 
life challenges that make them better prepared to face the 
challenges of a cancer diagnosis and treatment. Findings 
from other research studies investigating age differences 
are mixed. Some studies reported older patients had better 
mental HRQOL compared with younger patients after lung 
cancer surgery.26,47 Other studies found older patients had 
TABLE 2.   Mean PCSs and MCSs between Whites and Blacks
White Black
P ValueMean (SD)
PCS
time 1
38.1 (11.3) 38.0 (10.7) 0.97
MCS
time 1
51.3 (11.5) 48.9 (10.2) 0.13
PCS
time 2
39.5 (11.4) 38.9 (10.5) 0.74
MCS
time 2
52.6 (11.7) 47.4 (13.0) 0.002
Time 1: 4.1 (SD 2.2) months after surgery on average.
Time 2: 12.7 (SD 3.8) months after surgery on average.
MCS, mental component score, PCS, physical component score; SD, standard 
deviation.
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TABLE 3.  Linear Regression Analysis Explaining PCS (n = 650)
Variables
PCS
time 2
Model 1 Model 2 Model 3
β, 95% CI, p β, 95% CI, p β, 95% CI, p
Intercept 18.65, 14.44 to 22.86, <0.0001 22.76, 15.96 to 29.57, <0.0001 25.28, 16.18 to 34.38, <0.0001
PCS
time 1
0.58, 0.51 to 0.64, <0.0001 0.56, 0.49 to 0.62, <0.0001 0.55, 0.48 to 0.61, <0.0001
Race
  White 1.00 1.00 1.00
  Black −0.25, −2.76 to 2.26, 0.84 0.94, −1.59 to 3.47, 0.46 0.82, −1.70 to 3.34, 0.52
  Other −0.16, −2.49 to 2.16, 0.89 0.07, −2.23 to 2.36, 0.95 0.16, −2.15 to 2.46, 0.89
Age
  21–52 1.00 1.00 1.00
  53–64 −0.19, −3.07 to 2.68, 0.89 0.01, −2.80 to 2.81, 0.99 1.09, −1.82 to 4.00, 0.46
  65–79 1.14, −1.70 to 3.99, 0.43 1.31, −1.46 to 4.08, 0.35 3.88, 0.50 to 7.25, 0.02
  ≥80 2.17, −1.35 to 5.69, 0.22 1.79, −1.66 to 5.23, 0.30 4.38, 0.27 to 8.48, 0.03
Sex
  Female 1.00 1.00 1.00
  Male −2.20, −3.63 to −0.77, 0.002 −2.39, −3.84 to −0.92, 0.001 −2.24, −3.70 to −0.76, 0.002
Time since surgery −0.65, −0.24 to 0.12, 0.51 −0.06, −0.24 to 0.11, 0.46  −0.08, −0.26 to 0.09, 0.35
Marital status
  Married/living with partner 1.00 1.00
  Not married −1.08, −2.75 to 0.60, 0.20 −1.02, −2.68 to 0.64, 0.23
Income ($)
  ≥60,000 1.00 1.00
  <20,000 −2.82, −5.91 to 0.26, 0.07 −2.39, −5.48 to 0.70, 0.12
  20,000 to <40,000 0.003, −2.31 to 2.31, 0.99 0.25, −2.11 to 2.60, 0.83
  40,000 to <60,000 0.02, −2.60 to 2.63, 0.99 0.20, −2.36 to 2.75, 0.87
Education
  BS or higher 1.00 1.00
  Not HSg −2.95, −5.53 to −0.36, 0.02 −2.69, −5.31 to −0.07, 0.04
  HSg/less BS −2.24, −4.18 to −0.31, 0.02 −2.08, −4.01 to −0.14, 0.03
Social support
  EIS −0.02, −0.07 to 0.03, 0.38 −0.01, −0.05 to 0.03, 0.35
  Tangible −0.005, −0.05 to 0.03, 0.82 −0.02, −0.07 to 0.02, 0.73
Smoking status
  Current smokers 1.00 1.00
  Nonsmokers 2.17, −1.33 to 5.66, 0.20 2.03, −1.47 to 5.53, 0.23
Insurance
  Low income/other 1.00
  Medicare −2.17, −8.68 to 4.33, 0.83
  Private/VA/Mlt −0.63, −6.85 to 5.59, 0.50
Comorbidity
  None 1.00
  Mild −2.28, −4.52 to −0.05, 0.04
  Moderate −3.08, −5.43 to −0.72, 0.01
  Severe −4.44, −6.97 to −1.91, 0.0006
Stage
  I 1.00
  II −0.86, −2.82 to 1.09, 0.38
  IIIA 0.11, −2.36 to 2.58, 0.93
Type of surgery
  Limited resection 1.00
   LB/BB −0.04, −1.82 to 1.74, 0.96
   PN 1.70, −0.66 to 4.05, 0.15
Adjuvant chemotherapy
  No 1.00
  Yes 0.71, −0.93 to 2.35, 0.39
BB, bilobectomy; BS, bachelor degree; CI, confidence interval; EIS, emotional or informational support, HSg, high school graduate; LB, lobectomy; Mlt, military; PCS, physical 
component summary; PN, pneumonectomy; VA, Veteran’s administration.
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TABLE 4.  Linear Regression Analysis Explaining MCS (n = 650)
Variables
MCS
follow-up
Model 1 Model 2 Model 3
β, 95% CI, p β, 95% CI, p β, 95% CI, p
Intercept 19.08, 14.25 to 23.09, <0.0001 18.21, 11.98 to 24.44, <0.0001 17.79, 9.16 to 26.41, <0.0001
MCS
baseline
0.54, 0.47 to 0.60, <0.0001 0.51, 0.44 to 0.58, <0.001 0.51, 0.43 to 0.58, <0.0001
Race
  White 1.00 1.00 1.00
  Black −3.17, −5.83 to −0.51, 0.01 −2.93, −5.62 to −0.24, 0.03 −2.73, −5.41 to −0.05, 0.04
  Other −0.15, −2.59 to 2.29, 0.90 0.06, −2.37 to 2.49, 0.96 0.49, −1.95 to 2.92, 0.69
Age
  21–52 1.00 1.00 1.00
  53–64 2.80, −0.20 to 5.80, 0.06 2.91, −0.13 to 5.96, 0.06 3.32, 0.19 to 6.44, 0.03
  65–79 5.24, 2.30 to 8.17, 0.0005 5.45, 2.43 to 8.46, 0.0004 7.85, 4.22 to 11.48, <0.0001
  ≥80 5.50, 1.91 to 9.90, 0.002 5.78, 2.12 to 9.43, 0.002 9.03, 4.77 to 13.28, <0.0001
Sex
  Female 1.00 1.00 1.00
  Male 1.51, −0.00 to 3.03, 0.05 1.45, −0.10 to 3.01, 0.06 1.39, −0.17 to 2.95, 0.08
Time since surgery 0.04, −0.14 to 0.23, 0.64 0.06, −0.13 to 0.25, 0.54 0.05, −0.14 to 0.25, 0.57
Marital status
  Married 1.00 1.00
  Not married −0.31, −2.10 to 1.48, 0.73 −0.28, −2.07 to 1.51, 0.75
Income ($)
  ≥60,000 1.00 1.00
  <20,000 1.06, −1.58 to 3.71, 0.43 1.11, −1.58 to 3.81, 0.41
  20,000 to <40,000 −0.49, −2.94 to 1.95, 0.69 −0.53, −2.99 to 1.92, 0.66
  40,000 to <60,000 −0.26, −2.72 to 2.21, 0.83 −0.50, −2.99 to 1.98, 0.69
Education
  BS or higher 1.00 1.00
  Not HSg −3.69, −6.42 to −0.95, 0.008 −3.87, −6.59 to −1.15, 0.005
  HSg/less BS −0.75, −2.79 to 1.28, 0.46 −0.84, −2.87 to 1.19, 0.41
Social support
  EIS 0.04, −0.01 to 0.10, 0.09 0.04, −0.01 to 0.09, 0.11
  Tangible −0.005, −0.05 to 0.04, 0.80 −0.01, −0.05 to 0.04, 0.75
Smoking status
  Current smokers 1.00 1.00
  Nonsmokers 0.10, −2.81 to 3.02, 0.94 0.05, −2.72 to 2.82, 0.97
Insurance
  Low income 1.00
  Medicare −2.40, −9.16 to 4.35, 0.98
  Private/VA/Mlt 0.07, −6.47 to 6.63, 0.47
Comorbidity
  None 1.00
  Mild −0.40, −2.76 to 1.96, 0.73
  Moderate −0.98, −3.54 to 1.56, 0.44
  Severe 1.18, −1.59 to 3.95, 0.40
Stage
  Stage I 1.00
  Stage II 0.61, −1.47 to 2.69, 0.56
  Stage IIIA −0.35, −3.01 to 2.28, 0.78
Type of surgery
  Limited resection 1.00
   LB/BB 0.03, −1.83 to 1.90, 0.96
   PN −0.53, −3.04 to 1.96, 0.67
  Adjuvant chemotherapy
   No 1.00
   Yes 3.29, 1.56 to 5.02, 0.0002
BB, bilobectomy; BS, bachelor degree; CI, confidence interval; EIS, emotional or informational support, HSg, high school graduate; LB, lobectomy; Mlt, military; MCS, mental 
component summary; PN, pneumonectomy; VA, Veteran’s administration.
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lower physical HRQOL.8,47 Male patients had lower PCSs 
than women, which is not consistent with other studies that 
found no significant difference in physical HRQOL between 
men and women.8,47 More investigation is needed to under-
stand age and gender differences in HRQOL after lung can-
cer surgery. Not surprisingly, participants in this study with 
comorbidities had significantly lower physical HRQOL after 
lung cancer surgery that participants without comorbidities, 
which is consistent with previous reports.10,25,26,49
Other studies have reported that patients who received 
adjuvant chemotherapy after surgery experienced a decline in 
physical HRQOL but not in mental HRQOL.10 Similarly, we 
found that receipt of adjuvant chemotherapy after surgery was 
associated with a gain in MCS but not with PCS. One pos-
sible explanation might be that patients who received adju-
vant chemotherapy were more confident about their survival 
prospects because of active treatment. It is also possible that 
patients who received adjuvant chemotherapy were more fre-
quently followed during the postoperative period and receive 
more psychological counseling after surgery, which improves 
their mental condition. Future studies are needed to under-
stand how adjuvant chemotherapy after surgery affects mental 
health of patients.
There are several limitations to our study that should 
be noted. Physical and mental health variables were self-
reported and may not reflect true functional health status. 
HRQOL measures reflect the patients’ personal perspectives 
and may be affected by other factors such as patients’ posi-
tive/negative experiences with the provider or satisfaction of 
received care and variables not included in this study. Future 
studies will be required to investigate the effect of these fac-
tors on HRQOL after lung resection.
Although the CanCORS study made an effort to overs-
ample minority patients with lung cancer, we included more 
Whites than Blacks. Because of small sample sizes, Hispanic 
and other racial groups besides Blacks were collapsed into 
an “other” category. We dropped 194 patients because of 
missing one or more of the covariates needed for the mul-
tivariate analysis. Over one-half of dropped patients had 
advanced stage disease (IIIB/IV) at the time of the diagnosis. 
Therefore, our results may not be generalizable to patients 
with advanced-stage lung cancer. Also, deleted patients 
were more likely to be Black than White (14.4% versus 
8.8%). Research shows that minority patients and those with 
advanced-stage cancer are less likely to enroll in studies.50 
Future studies are needed to include more minority groups.
In summary, this study generated potentially useful 
information about racial differences in HRQOL for people 
with NSCLC who received surgery for their disease. Blacks 
had lower mental health as measured by the SF-12 after 
surgery than Whites. These finding suggest that Black race 
influences mental health above and beyond socioeconomic 
status and clinical factors. There were age-related differences 
in both physical and mental HRQOL after surgery for lung 
cancer. In particular, these results provide important informa-
tion for informed decision making for patients with operable 
NSCLC. Health care providers should be aware of subgroups 
of lung cancer patients, such as Blacks, patients with younger 
age, and lower levels of education who are at higher risk for 
poorer mental health after lung cancer surgery. The study 
findings also highlight the need for screening for psychoso-
cial issues before and after lung cancer surgery to identify 
those who may benefit from targeted interventions to improve 
mental health and psychosocial outcomes in survivorship. 
Future studies are needed to explain risk factors for poor 
mental health among Black patients. Disparities in HRQOL 
by race persist among lung cancer patients, and understand-
ing the reasons for racial differences in mental health will 
inform the development of effective, culturally appropriate 
interventions to enhance HRQOL after lung cancer surgery. 
Efforts to address HRQOL among Blacks may ultimately 
improve lung cancer survival.
ACKNOWLEDGMENTS
The work of the CanCORS consortium was supported 
by grants from the National Cancer Institute (NCI) to the 
Statistical Coordinating Center (U01 CA093344) and the 
NCI supported Primary Data Collection and Research 
Centers (Dana-Farber Cancer Institute/Cancer Research 
Network U01 CA093332, Harvard Medical School/Northern 
California Cancer Center U01 CA093324, RAND/UCLA 
U01 CA093348, University of Alabama at Birmingham U01 
CA093329, University of Iowa U01 CA093339, University 
of North Carolina U01 CA 093326) and by a Department of 
Veteran’s Affairs grant to the Durham VA Medical Center VA 
HSRD CRS-02-164).
REFERENCES
 1. Siegel R, Ma J, Zou Z, et al. Cancer statistics. CA Cancer J Clin 2014; 
64:9–29.
 2. Traeger L, Cannon S, Pirl WF, Park ER. Depression and undertreatment 
of depression: potential risks and outcomes in black patients with lung 
cancer. J Psychosoc Oncol 2013;31:123–135.
 3. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics 
Review, 1975–2008. Bethesda, MD: National Cancer Institute, 2011. 
Available at: http://seer.cancer.gov/csr/1975_2008/ (based on November 
2010 SEER data submission, posted to the SEER web site). Accessed 
December 21, 2013. 
 4. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact 
of eliminating socioeconomic and racial disparities on premature cancer 
deaths. CA Cancer J Clin 2011;61:212–236.
 5. Lathan CS, Neville BA, Earle CC. The effect of race on invasive staging 
and surgery in non-small-cell lung cancer. J Clin Oncol 2006;24:413–418.
 6. Esnaola NF, gebregziabher M, Knott K, et al. Underuse of surgical resec-
tion for localized, non-small cell lung cancer among whites and African 
Americans in South Carolina. Ann Thorac Surg 2008;86:220–226; dis-
cussion 227.
 7. Manser R, Wright g, Hart D, et al. Surgery for local and locally advanced 
non-small cell lung cancer. Cochrane Database of Systematic Reviews 1 
2005. Art. No. CD004699.
 8. Möller A, Sartipy U. Predictors of postoperative quality of life after sur-
gery for lung cancer. J Thorac Oncol 2012;7:406–411.
 9. Kenny PM, King MT, Viney RC, et al. Quality of life and survival in 
the 2 years after surgery for non small-cell lung cancer. J Clin Oncol 
2008;26:233–241.
 10. Poghosyan H, Sheldon LK, Leveille Sg, Cooley ME. Health-related qual-
ity of life after surgical treatment in patients with non-small cell lung 
cancer: a systematic review. Lung Cancer 2013;81:11–26.
 11. Balduyck B, Hendriks J, Lauwers P, Sardari Nia P, Van Schil P. Quality of 
life evolution after lung cancer surgery in septuagenarians: a prospective 
study. Eur J Cardiothorac Surg 2009;35:1070–1075; discussion 1075.
Copyright © 2015 by the International Association for the Study of Lung Cancer
1412 Copyright © 2015 by the International Association for the Study of Lung Cancer
Poghosyan et al. Journal of Thoracic Oncology ®  •  Volume 10, Number 10, October 2015
 12. Burfeind WR Jr, Tong BC, O’Branski E, et al. Quality of life outcomes 
are equivalent after lobectomy in the elderly. J Thorac Cardiovasc Surg 
2008;136:597–604.
 13. Ye J, Shim R, garrett SL, Daniels E. Health-related quality of life in 
elderly black and white patients with cancer: results from Medicare man-
aged care population. Ethn Dis 2012;22:302–307.
 14. Möller A, Sartipy U. Associations between changes in quality of life and 
survival after lung cancer surgery. J Thorac Oncol 2012;7:183–187.
 15. DeNavas-Walt C, Proctor BD, Smith JC. Income, Poverty, and Health 
Insurance Coverage in the United States: 2009. Washington, DC: U.S. 
Census Bureau Publication, 2010. Pp. 60–238.
 16. Ryan CL, Sieben J. Educational Attainment in the United States: 2009. 
Washington, DC: U.S. Census Bureau Publication, 2012. Pp. 20–566.
 17. Walker gV, grant SR, guadagnolo BA, et al. Disparities in stage at diag-
nosis, treatment, and survival in nonelderly adult patients with cancer 
according to insurance status. J Clin Oncol 2014;32:3118–3125.
 18. Halpern MT, Ward EM, Pavluck AL, Schrag NM, Bian J, Chen AY. 
Association of insurance status and ethnicity with cancer stage at 
diagnosis for 12 cancer sites: a retrospective analysis. Lancet Oncol 
2008;9:222–231.
 19. U.S. Census Bureau. Statistical Abstracts of the United States (ed 131) 
Washington, DC: U.S. Census Bureau, 2012.
 20. Yang R, Cheung MC, Byrne MM, et al. Do racial or socioeconomic dis-
parities exist in lung cancer treatment? Cancer 2010;116:2437–2447.
 21. Williams CD, Stechuchak KM, Zullig LL, Provenzale D, Kelley MJ. 
Influence of comorbidity on racial differences in receipt of surgery 
among US veterans with early-stage non-small-cell lung cancer. J Clin 
Oncol 2013;31:475–481.
 22. Tammemagi CM, Neslund-Dudas C, Simoff M, Kvale P. In lung cancer 
patients, age, race-ethnicity, gender and smoking predict adverse comor-
bidity, which in turn predicts treatment and survival. J Clin Epidemiol 
2004;57:597–609.
 23. Park ER, Japuntich SJ, Traeger L, Cannon S, Pajolek H. Disparities 
between blacks and whites in tobacco and lung cancer treatment. 
Oncologist 2011;16:1428–1434.
 24. Balduyck B, Sardari Nia P, Cogen A, et al. The effect of smoking cessa-
tion on quality of life after lung cancer surgery. Eur J Cardiothorac Surg 
2011;40:1432–1437; discussion 1437.
 25. Sarna L, Cooley ME, Brown JK, et al. Women with lung cancer: qual-
ity of life after thoracotomy: a 6-month prospective study. Cancer Nurs 
2010;33:85–92.
 26. Ostroff JS, Krebs P, Coups EJ, et al. Health-related quality of life 
among early-stage, non-small cell, lung cancer survivors. Lung Cancer 
2011;71:103–108.
 27. Sartipy U. Prospective population-based study comparing quality of 
life after pneumonectomy and lobectomy. Eur J Cardiothorac Surg 
2009;36:1069–1074.
 28. Williams DR, Kontos EZ, Viswanath K, et al. Integrating multiple social 
statuses in health disparities research: the case of lung cancer. Health Serv 
Res 2012;47(3 Pt 2):1255–1277.
 29. Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of 
cancer treatment. J Natl Cancer Inst 2002;94:334–357.
 30. Smedley BD, Stith AY, Nelson AR. Unequal Treatment. Washington, 
DC: National Academies Press, Institute of Medicine of the National 
Academics, 2003.
 31. Traeger L, Cannon S, Keating NL, et al. Race by sex differences in depres-
sion symptoms and psychosocial service use among non-Hispanic black 
and white patients with lung cancer. J Clin Oncol 2014;32:107–113.
 32. Ayanian JZ, Chrischilles EA, Fletcher RH, et al. Understanding can-
cer treatment and outcomes: the Cancer Care Outcomes Research and 
Surveillance Consortium. J Clin Oncol 2004;22:2992–2996.
 33. Ayanian JZ, Zaslavsky AM, Arora NK, et al. Patients’ experiences with 
care for lung cancer and colorectal cancer: findings from the Cancer 
Care Outcomes Research and Surveillance Consortium. J Clin Oncol 
2010;28:4154–4161.
 34. Catalano PJ, Ayanian JZ, Weeks JC, et al.; Cancer Care Outcomes Research 
Surveillance Consortium. Representativeness of participants in the cancer 
care outcomes research and surveillance consortium relative to the surveil-
lance, epidemiology, and end results program. Med Care 2013;51:e9–e15.
 35. Keating NL, Beth Landrum M, Arora NK, et al. Cancer patients’ roles 
in treatment decisions: do characteristics of the decision influence roles? 
J Clin Oncol 2010;28:4364–4370.
 36. He Y, Zaslavsky AM, Landrum MB, Harrington DP, Catalano P. Multiple 
imputation in a large-scale complex survey: a practical guide. Stat 
Methods Med Res 2010;19:653–670.
 37. Little RJ, Rubin DB. Statistical Analysis with Missing Data. New York, 
NY: John Wiley & Sons, 1986.
 38. Ware J Jr, Kosinski M, Keller SD. A 12-item short-form health survey: 
construction of scales and preliminary tests of reliability and validity. 
Med Care 1996;34:220–233.
 39. Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci 
Med 1991;32:705–714.
 40. American Joint Committee on Cancer. AJCC Cancer Staging Atlas. 
Chicago, IL: Springerlink, 2006.
 41. Piccirillo JF, Costas I, Claybour P, et al. The measurement of comorbidity 
by cancer regristries. J Registry Manage 2003; 30:8–14.
 42. Treanor C, Donnelly M. An international review of the patterns and 
determinants of health service utilisation by adult cancer survivors. BMC 
Health Serv Res 2012;12:316.
 43. Johnson KS, Elbert-Avila KI, Tulsky JA. The influence of spiritual beliefs 
and practices on the treatment preferences of African Americans: a review 
of the literature. J Am Geriatr Soc 2005;53:711–719.
 44. Jacobsen PB, Wagner LI. A new quality standard: the integration of psy-
chosocial care into routine cancer care. J Clin Oncol 2012;30:1154–1159.
 45. Wagner LI, Spiegel D, Pearman T. Using the science of psychosocial care 
to implement the new American college of surgeons commission on cancer 
distress screening standard. J Natl Compr Canc Netw 2013;11:214–221.
 46. Adler NE, Page AEK. Cancer Care for the Whole Patient: Meeting 
Psychosocial Health Needs. Washington, DC: Institute of Medicine, 
National Academy Press, 2008.
 47. Möller A, Sartipy U. Long-term health-related quality of life following 
surgery for lung cancer. Eur J Cardiothorac Surg 2012;41:362–367.
 48. Alberg AJ, Ford Jg, Samet JM; American College of Chest Physicians. 
Epidemiology of lung cancer: ACCP evidence-based clinical practice 
guidelines (2nd edition). Chest 2007;132(3 Suppl):29S–55S.
 49. Hewitt M, Rowland JH, Yancik R. Cancer survivors in the United States: 
age, health, and disability. J Gerontol A Biol Sci Med Sci 2003;58:82–91.
 50. Fouad MN, Lee JY, Catalano PJ, et al. Enrollment of patients with 
lung and colorectal cancers onto clinical trials. J Oncol Pract 
2013;9:e40–e47.
